Literature DB >> 3186716

Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes.

H Peng1, D Armentano, L MacKenzie-Graham, R F Shen, G Darlington, F D Ledley, S L Woo.   

Abstract

Genetic therapy for phenylketonuria (severe phenylalanine hydroxylase deficiency) may require introduction of a normal phenylalanine hydroxylase gene into hepatic cells of patients. We report development of a recombinant retrovirus based on the N2 vector for gene transfer and expression of human phenylalanine hydroxylase cDNA in primary mouse hepatocytes. This construct contains an internal promoter of the human alpha 1-antitrypsin gene driving transcription of the phenylalanine hydroxylase cDNA. Primary mouse hepatocytes were isolated from newborn mice, infected with the recombinant virus, and selected for expression of the neomycin-resistance gene. Hepatocytes transformed with the recombinant virus contained high levels of human phenylalanine hydroxylase mRNA transcripts originating form the retroviral and internal promoters. These results demonstrate that the transcriptional regulatory elements of the alpha 1-antitrypsin gene retain their tissue-specific function in the recombinant provirus and establish a method for efficient transfer and high-level expression of human phenylalanine hydroxylase in primary hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3186716      PMCID: PMC282383          DOI: 10.1073/pnas.85.21.8146

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

5.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors:  J Banerji; S Rusconi; W Schaffner
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

6.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Differential expression of the members of the discoidin I multigene family during growth and development of Dictyostelium discoideum.

Authors:  J M Devine; A S Tsang; J G Williams
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

8.  Studies on human phenylalanine Mono-oxygenase. I. Restricted expression.

Authors:  M D Crawfurd; D A Gibbs; D M Sheppard
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

Review 9.  Phenylketonuria: epitome of human biochemical genetics (first of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

Review 10.  Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.

Authors:  F Güttler
Journal:  Acta Paediatr Scand Suppl       Date:  1980
View more
  11 in total

1.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.

Authors:  M A Kay; P Baley; S Rothenberg; F Leland; L Fleming; K P Ponder; T Liu; M Finegold; G Darlington; W Pokorny
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 3.  Somatic gene therapy for phenylketonuria and other hepatic deficiencies.

Authors:  R C Eisensmith; S L Woo
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex.

Authors:  R J Cristiano; L C Smith; M A Kay; B R Brinkley; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.

Authors:  D Armentano; A R Thompson; G Darlington; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas.

Authors:  L D Teeter; F F Becker; F V Chisari; D J Li; M T Kuo
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 7.  Gene therapy for phenylketonuria.

Authors:  R C Eisensmith; S L Woo
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  State-of-the-art 2003 on PKU gene therapy.

Authors:  Zhaobing Ding; Cary O Harding; Beat Thöny
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

9.  Transduction of primary human hepatocytes with amphotropic and xenotropic retroviral vectors.

Authors:  R M Adams; H E Soriano; M Wang; G Darlington; D Steffen; F D Ledley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase.

Authors:  J D McDonald; V C Bode; W F Dove; A Shedlovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.